➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
McKinsey
Mallinckrodt
AstraZeneca
Baxter

Last Updated: October 20, 2021

DrugPatentWatch Database Preview

ACTIGALL Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

Which patents cover Actigall, and when can generic versions of Actigall launch?

Actigall is a drug marketed by Allergan and is included in one NDA.

The generic ingredient in ACTIGALL is ursodiol. There are eight drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the ursodiol profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Actigall

A generic version of ACTIGALL was approved as ursodiol by EPIC PHARMA on March 14th, 2000.

  Free Forever Trial

Drug patent expirations by year for ACTIGALL
Drug Prices for ACTIGALL

See drug prices for ACTIGALL

Recent Clinical Trials for ACTIGALL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
The University of Texas Health Science Center at San AntonioPhase 2
Ann & Robert H Lurie Children's Hospital of ChicagoPhase 1
University of Colorado, DenverPhase 1

See all ACTIGALL clinical trials

US Patents and Regulatory Information for ACTIGALL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan ACTIGALL ursodiol CAPSULE;ORAL 019594-001 Dec 31, 1987 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Allergan ACTIGALL ursodiol CAPSULE;ORAL 019594-002 Dec 31, 1987 AB RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
McKinsey
Mallinckrodt
AstraZeneca
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.